Trichorhinophalangeal syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:324764
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Trichorhinophalangeal syndrome (TRPS) is a rare genetic condition that affects the growth and development of bones, joints, and hair. The Orphanet code 324764 refers to the broader grouping of TRPS types. There are three main types: TRPS type I, TRPS type II (also called Langer-Giedion syndrome), and TRPS type III. All types share certain features, but they vary in severity. The hallmark features of TRPS include sparse, thin hair that grows slowly, a distinctive pear-shaped or bulbous nose, and short fingers and toes with cone-shaped growth plates (called cone-shaped epiphyses). People with TRPS often have short stature and may develop early joint problems similar to arthritis, especially in the hips. TRPS type II can also include intellectual disability and multiple bony growths called exostoses. There is no cure for TRPS, so treatment focuses on managing symptoms. This may include orthopedic care for joint and bone problems, growth hormone therapy for short stature in some cases, and supportive therapies. Early diagnosis helps families plan appropriate medical follow-up and support throughout life.

Key symptoms:

Thin, sparse, slow-growing hairBulbous or pear-shaped noseShort fingers and toes (brachydactyly)Short statureHip joint pain or early arthritisCone-shaped growth plates in the finger bonesThin upper lipProminent earsLoose or overly flexible joints in childhoodStiff or painful joints later in lifeBony bumps or growths on bones (in TRPS type II)Mild to moderate intellectual disability (mainly in TRPS type II)Delayed bone ageFlat feet

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Trichorhinophalangeal syndrome.

View clinical trials →

No actively recruiting trials found for Trichorhinophalangeal syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Trichorhinophalangeal syndrome community →

No specialists are currently listed for Trichorhinophalangeal syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Trichorhinophalangeal syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Trichorhinophalangeal syndromeForum →

No community posts yet. Be the first to share your experience with Trichorhinophalangeal syndrome.

Start the conversation →

Latest news about Trichorhinophalangeal syndrome

No recent news articles for Trichorhinophalangeal syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which type of trichorhinophalangeal syndrome does my child (or do I) have?,How often should we have X-rays or imaging to monitor the hips and joints?,Would growth hormone therapy be appropriate in this case?,What physical activities are safe, and which should be avoided to protect the joints?,Are there any signs of complications I should watch for at home?,Should other family members be tested for this condition?,What support services are available for learning or developmental needs?

Common questions about Trichorhinophalangeal syndrome

What is Trichorhinophalangeal syndrome?

Trichorhinophalangeal syndrome (TRPS) is a rare genetic condition that affects the growth and development of bones, joints, and hair. The Orphanet code 324764 refers to the broader grouping of TRPS types. There are three main types: TRPS type I, TRPS type II (also called Langer-Giedion syndrome), and TRPS type III. All types share certain features, but they vary in severity. The hallmark features of TRPS include sparse, thin hair that grows slowly, a distinctive pear-shaped or bulbous nose, and short fingers and toes with cone-shaped growth plates (called cone-shaped epiphyses). People with T

How is Trichorhinophalangeal syndrome inherited?

Trichorhinophalangeal syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Trichorhinophalangeal syndrome typically begin?

Typical onset of Trichorhinophalangeal syndrome is childhood. Age of onset can vary across affected individuals.